Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 15, 2022 05:08 ET | Source: Research and Markets

Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market to Cross $1.52 Billion by 2030 - What Are the Most Investment-Attractive Products, Segments, Applications, and Areas?

Dublin, March 15, 2022 (GLOBE NEWSWIRE) -- The "Global Chemotherapy-Induced Peripheral Neuropathy Market, By Therapy, By Region, Estimation & Forecast, 2017 - 2030" report has been added to...
March 14, 2022 08:00 ET | Source: Applied Molecular Transport Inc.

Applied Molecular Transport Appoints Industry Veteran Carolyn Finkle as Senior Vice President, Head of Regulatory Affairs

Company continues to strengthen key functions and corporate leadership Company on track to announce top-line data from four ongoing oral AMT-101 Phase 2 trials in 2022 SOUTH SAN FRANCISCO, Calif.,...
March 14, 2022 03:00 ET | Source: Verona Pharma plc

James Brady Joins Verona Pharma as Non-Executive Director

LONDON and RALEIGH, N.C., March 14, 2022 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces...
February 28, 2022 08:00 ET | Source: Noema Pharma

Noema Pharma Appoints Michael Gutch as Chief Financial Officer

BASEL, Switzerland, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Noema Pharma, a Swiss-based clinical stage company targeting orphan central nervous system (CNS) diseases, today announces the appointment of...
February 17, 2022 16:15 ET | Source: NexImmune, Inc.

NexImmune Appoints Kristi Jones as Chief Executive Officer and Member of the Board of Directors

GAITHERSBURG, Md., Feb. 17, 2022 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a...
February 15, 2022 07:00 ET | Source: ArriVent Biopharma

ArriVent Biopharma Appoints Bahija Jallal to its Board of Directors

NEWTOWN SQUARE, Pa., Feb. 15, 2022 (GLOBE NEWSWIRE) -- ArriVent Biopharma, Inc., industry leaders dedicated to accelerating the global development of innovative biopharmaceutical products, today...
February 02, 2022 16:05 ET | Source: Adagene, Inc.

Adagene Announces Board and Management Appointments to Support Pipeline Growth

SAN DIEGO and SUZHOU, China, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of antibody-based therapies, today...
January 31, 2022 06:44 ET | Source: Facts & Factors

Global Blood and Blood Components Market Size is Climbing by 5.4% CAGR from 2021-2026 To Approach USD 47,000 Million - Facts & Factors

NEW YORK, United States, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled Blood and “Blood Components Market By Product (Whole Blood, and Blood...
January 12, 2022 07:30 ET | Source: APIE Therapeutics

APIE Therapeutics Augments Leadership Team with Addition of Chief Business Officer and Chief Medical Officer

Cary, NC, Jan. 12, 2022 (GLOBE NEWSWIRE) -- APIE Therapeutics, a preclinical biopharma company pioneering microvasculature endothelium drug development by targeting the apelin receptor (APJ),...
January 05, 2022 08:00 ET | Source: Icosavax, Inc.

Icosavax Appoints Dr. John Shiver to Board of Directors

SEATTLE, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines...